U.S. Markets closed
  • S&P 500

    4,410.13
    +12.19 (+0.28%)
     
  • Dow 30

    34,364.50
    +99.10 (+0.29%)
     
  • Nasdaq

    13,855.13
    +86.23 (+0.63%)
     
  • Russell 2000

    1,987.92
    -36.12 (-1.78%)
     
  • Crude Oil

    0 (0)
     
  • Gold

    1,836.10
    -6.50 (-0.35%)
     
  • Silver

    24.34
    -0.37 (-1.50%)
     
  • EUR/USD

    1.1348
    +0.0031 (+0.2724%)
     
  • 10-Yr Bond

    1.7350
    -0.0120 (-0.69%)
     
  • Vix

    28.85
    +3.26 (+12.74%)
     
  • GBP/USD

    1.3555
    -0.0045 (-0.3321%)
     
  • USD/JPY

    113.6500
    -0.4500 (-0.3944%)
     
  • BTC-USD

    36,577.52
    +472.91 (+1.31%)
     
  • CMC Crypto 200

    839.82
    +29.21 (+3.60%)
     
  • FTSE 100

    7,494.13
    -90.88 (-1.20%)
     
  • Nikkei 225

    27,522.26
    -250.64 (-0.90%)
     

'Halftime Report' Traders Advise Viewers On Greenbrier Companies, Exelon And More

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • GBX
  • EXC

On CNBC's "Fast Money Halftime Report," Stephen Weiss said Brookfield Renewable Partners LP (NYSE: BEP) is the future. The company is signing long term agreements and Weiss would rather own this stock than Chevron Corporation (NYSE: CVX).

Jim Lebenthal said Greenbrier Companies Inc (NYSE: GBX) is a great stock for the long term, but he sees it as a hold in the short term. Lebenthal advised viewers with a long position to hold the stock. Investors that don't own the stock should wait for a pullback, thinks Lebenthal.

Jenny Harrington sees Exelon Corporation (NASDAQ: EXC) as a great investment. She likes its 3.9% dividend yield. She wishes she owned it, but she doesn't.

Michael Farr owns Abbott Laboratories (NYSE: ABT) and Medtronic PLC (NYSE: MDT), but he thinks they are kind of expensive. Abbott Labs is the best in class, believes Farr. He also owns Becton Dickinson and Co (NYSE: BDX) and he has just doubled his position in the stock. He thinks Becton Dickinson is a better buy than Abbott Labs and Medtronic.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.